| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |